Transfer Factor (TLCO / DLCO)
Definition 📊: Transfer factor (also called TLCO or DLCO) measures how efficiently gases (mainly carbon monoxide) move across the alveolar–capillary membrane into the pulmonary capillaries. It is a standard lung function test.
How it is Measured 🧪
- Patient inhales a small amount of carbon monoxide (CO) with an inert tracer gas (usually helium).
- CO uptake is measured because CO has very high affinity for Hb and is normally absent in inspired air.
- The test reflects the surface area and integrity of the alveolar–capillary interface and the haemoglobin available to bind CO.
Determinants of TLCO 🔬
- Alveolar surface area - reduced in emphysema.
- Membrane thickness - increased in interstitial lung disease (ILD).
- Pulmonary capillary blood volume - affected by pulmonary hypertension or anaemia.
- Haemoglobin concentration - anaemia ↓ TLCO; polycythaemia ↑ TLCO.
Common Causes of Reduced TLCO ⬇️
- Emphysema - loss of alveolar surface area.
- Interstitial lung diseases (e.g. idiopathic pulmonary fibrosis, sarcoidosis).
- Pulmonary vascular disease - pulmonary hypertension, recurrent PE.
- Anaemia - less Hb available for binding CO.
Common Causes of Increased TLCO ⬆️
- Asthma (due to increased pulmonary blood volume and capillary recruitment).
- Polycythaemia (more Hb binding sites).
- Left-to-right cardiac shunts (increased pulmonary blood flow).
Clinical Use 💡
- Helps differentiate obstructive diseases:
- Emphysema: Low TLCO.
- Asthma: Normal or high TLCO.
- Assists in evaluating ILD severity and monitoring progression.
- Used in pre-operative assessment (e.g. lung resection, transplant suitability).
- Part of work-up in unexplained breathlessness or suspected pulmonary vascular disease.
Teaching Point 🩺: TLCO is a window into the alveolar–capillary unit. Think of it as a “functional biopsy” of gas exchange efficiency. Always interpret alongside KCO (TLCO corrected for alveolar volume) to distinguish between loss of lung volume vs intrinsic membrane disease.
3 Clinical Cases - Low Transfer Capacity (DLCO) 🫁
- Case 1 - Interstitial lung disease 🌫️: A 66-year-old retired builder with progressive breathlessness and dry cough. Ex-smoker, 20 pack-years. Exam: fine bibasal inspiratory crackles, finger clubbing. Spirometry shows restrictive pattern (low FVC, preserved FEV1/FVC), and DLCO is markedly reduced. Teaching: DLCO falls because fibrotic interstitial thickening increases diffusion distance. Classic in idiopathic pulmonary fibrosis and connective-tissue–related ILD.
- Case 2 - Pulmonary vascular disease 💓: A 45-year-old woman with systemic sclerosis presents with worsening exertional dyspnoea. Echo suggests pulmonary hypertension. Spirometry is normal, lung volumes preserved, but DLCO is severely reduced. Teaching: In pulmonary arterial hypertension, alveolar structure is preserved but pulmonary capillary bed is obliterated → gas transfer falls disproportionately compared to spirometry.
- Case 3 - Emphysema due to COPD 🚬: A 59-year-old man with chronic cough and 35 pack-year smoking history. Exam: hyperinflated chest, reduced breath sounds. Spirometry shows obstructive pattern (low FEV1, low FEV1/FVC), lung volumes high, but DLCO is reduced. Teaching: In emphysema, alveolar wall destruction reduces surface area for diffusion, explaining the low transfer factor. This finding helps differentiate emphysema from chronic bronchitis.
